A Dose Ranging Study Of GW640385 Boosted With Ritonavir (Rtv) In Comparison To A RTV-Boosted Protease Inhibitor (PI) In HIV-1 Infected PI-Experienced Adults

Clinical trial NCT00242879 · TERMINATED

Trial details

NCT number: NCT00242879
Sponsor: ViiV Healthcare
Status: TERMINATED
Phase: Phase 2
Study type: INTERVENTIONAL

Infection, Human Immunodeficiency Virus I HIV-1 Infection

Start date: 2005-08-01
Primary completion: 2007-06-01
Enrollment: 130

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.